Related Experiment Video
Updated: Apr 27, 2026
Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
Published on: February 9, 2019
Novel prospects of statins as therapeutic agents in cancer
Simona Pisanti1, Paola Picardi1, Elena Ciaglia1
1Department of Medicine and Surgery, University of Salerno, Italy; Department of Pharmacy, University of Salerno, Italy.
Abstract:
Statins are well known competitive inhibitors of hydroxymethylglutaryl-CoA reductase enzyme (HMG-CoA reductase), thus traditionally used as cholesterol-lowering agents. In recent years, more and more effects of statins have been revealed. Nowadays alterations of lipid metabolism have been increasingly recognized as a hallmark of cancer cells. Consequently, much attention has been directed toward the potential of statins as therapeutic agents in the oncological field. Accumulated in vitro and in vivo clinical evidence point out the role of statins in a variety of human malignancies, in regulating tumor cell growth and anti-tumor immune response. Herein, we summarize and discuss, in light of the most recent observations, the anti-tumor effects of statins, underpinning the detailed mode of action and looking for their true significance in cancer prevention and treatment, to determine if and in which case statin repositioning could be really justified for neoplastic diseases.
Insights
Statins, traditionally used for cholesterol, show promising anti-tumor effects by regulating cancer cell growth and immune response. Research explores their potential for cancer prevention and treatment, justifying repositioning for neoplastic diseases.
Area of Science:
- Oncology
- Pharmacology
- Biochemistry
Background:
- Statins are competitive inhibitors of HMG-CoA reductase, primarily used as cholesterol-lowering agents.
- Altered lipid metabolism is a recognized hallmark of cancer cells, prompting interest in statins for cancer therapy.
- Emerging evidence highlights statins' role in modulating tumor cell growth and anti-tumor immunity.
Purpose of the Study:
- To summarize and discuss the anti-tumor effects of statins based on recent observations.
- To elucidate the detailed mechanisms of action of statins in cancer.
- To evaluate the significance of statins in cancer prevention and treatment for potential repositioning.
Main Methods:
- Review and synthesis of in vitro and in vivo clinical evidence.
- Analysis of recent scientific observations on statin activity in malignancies.
- Discussion of mechanisms regulating tumor cell growth and anti-tumor immune response.
Main Results:
- Statins exhibit anti-tumor effects across various human malignancies.
- Statins influence tumor cell proliferation and modulate the anti-tumor immune response.
- Evidence supports the potential role of statins in cancer therapy.
Conclusions:
- Statins demonstrate significant anti-tumor properties beyond cholesterol reduction.
- Understanding statin mechanisms is crucial for their application in oncology.
- Statin repositioning for neoplastic diseases warrants further investigation and justification.
More Related Videos
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:57Targeted Cancer Therapies
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
01:15Drugs that Stabilize Microtubules